Page 1 of Clinical Trials for "Brimonidine", 77 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%
Last Updated: January 4, 2012
Condition(s): Erythematous Rosacea
2
Completed
Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Last Updated: January 31, 2012
Condition(s): Glaucoma; Ocular Hypertension
3
Active, not recruiting
Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)
Last Updated: June 30, 2011
Condition(s): Macular Degeneration
4
Active, not recruiting
Three Month Efficacy/Safety Study With a 3 Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Last Updated: November 29, 2011
Condition(s): Open Angle Glaucoma; Ocular Hypertension
5
Completed
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Last Updated: April 1, 2008
Condition(s): Glaucoma; Ocular Hypertension
6
Terminated
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
Last Updated: March 10, 2010
Condition(s): Open-Angle Glaucoma; Ocular Hypertension
7
Completed
Efficacy and Safety Study of Brinzolamide 1% / Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
Last Updated: May 4, 2012
Condition(s): Open-angle Glaucoma; Ocular Hypertension
8
Not yet recruiting
Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
Last Updated: December 1, 2008
Condition(s): Corneal Edema; Visual Acuity
9
Completed
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
Last Updated: December 14, 2011
Condition(s): Open-angle Glaucoma; Ocular Hypertension
10
Completed
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
Last Updated: August 1, 2011
Condition(s): Glaucoma; Ocular Hypertension
11
Recruiting
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
Last Updated: November 30, 2011
Condition(s): Open-angle Glaucoma; Ocular Hypertension
12
Completed
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa
Last Updated: February 2, 2011
Condition(s): Retinitis Pigmentosa
13
Completed
Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy
Last Updated: January 26, 2012
Condition(s): Glaucoma; Optic Neuropathy
14
Completed
24-hour IOP-lowering Effect of Brimonidine 0.1%
Last Updated: October 18, 2011
Condition(s): Open-angle Glaucoma; Ocular Hypertension
15
Completed
Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy
Last Updated: April 27, 2012
Condition(s): Vitrectomy
16
Completed
Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
Last Updated: May 6, 2008
Condition(s): Primary Open Angle Glaucoma; Ocular Hypertension
17
Recruiting
Efficacy and Safety of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination BID vs. Brinzolamide 1% BID Plus Brimonidine 0.2% BID
Last Updated: November 30, 2011
Condition(s): Open-angle Glaucoma or Ocular Hypertension
18
Recruiting
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy
Last Updated: April 28, 2011
Condition(s): Glaucoma
19
Completed
Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab
Last Updated: March 18, 2009
Condition(s): Age Related Macular Degeneration; Diabetic Retinopathy
20
Completed
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Last Updated: March 2, 2012
Condition(s): Allergic Conjunctivitis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Brimonidine%22

Page 1 of Clinical Trials for "Brimonidine", 77 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About